cytarabine liposome
Term · Oncology and biomedicine · MLC-T-ONC-012879
A liposomal intrathecal formulation of the antimetabolite cytarabine. As an S-phase-specific antimetabolite, cytarabine is phosphorylated by deoxycytidine kinase to a triphosphate form which competes with thymidine for incorporation into DNA; the incorporation of cytarabine triphosphate into DNA appears to inhibit DNA polymerase and so DNA synthesis, resulting in cell death.
| Identifier | MLC-T-ONC-012879 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | cytarabine liposomal; Liposomal Ara-C; DepoFoam encapsulated cytarabine; encapsulated cytarabine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012879",
"term": "cytarabine liposome",
"field": "Oncology and biomedicine",
"definition": "A liposomal intrathecal formulation of the antimetabolite cytarabine. As an S-phase-specific antimetabolite, cytarabine is phosphorylated by deoxycytidine kinase to a triphosphate form which competes with thymidine for incorporation into DNA; the incorporation of cytarabine triphosphate into DNA appears to inhibit DNA polymerase and so DNA synthesis, resulting in cell death.",
"synonyms": [
"cytarabine liposomal",
"Liposomal Ara-C",
"DepoFoam encapsulated cytarabine",
"encapsulated cytarabine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/cytarabine-liposome/"
}
Record 5,606 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.